HIV Diagnosis Using Fourth-Generation Tests

Test Characteristics and Recommendations

The Centers for Disease Control and Prevention recommends that fourth-generation HIV tests be considered conclusive after 12 weeks of potential exposure, with both antigen/antibody (Ag/Ab) testing and nucleic acid testing (NAT) performed at this time to confirm the final result 1
The American Academy of Family Physicians recommends using fourth-generation antigen/antibody tests because they can detect recent infection a few weeks before standard antibody tests 2

Initial testing should include a rapid (point-of-care) or laboratory antigen/antibody test, with laboratory testing recommended to increase sensitivity for HIV detection 1
If a rapid test is used, a laboratory antigen/antibody test is also recommended to increase sensitivity for HIV detection 1
Follow-up testing at 4-6 weeks should include laboratory antigen/antibody testing with NAT, which can be delayed for individuals who started post-exposure prophylaxis (nPEP) within 24 hours of potential exposure and completed the full course 1
Final, definitive testing at 12 weeks should include both laboratory antigen/antibody testing and NAT, based on data regarding the timeline for antiviral medication washout and the window period for HIV tests 1, 3

Antiretroviral medications taken as post-exposure prophylaxis (PEP) or pre-exposure prophylaxis (PrEP) can suppress viral load, delay antibody formation, and reduce the ability to detect HIV infection 1
Rapid HIV tests based on oral fluids are not recommended for testing in the context of post-exposure prophylaxis services because they are less sensitive for detecting acute or recent infection than blood tests 1
Initiation of nPEP should not be delayed pending HIV test results or assessment of the source person's risk factors 2

The Centers for Disease Control and Prevention recommends performing laboratory-based HIV Ag/Ab testing at baseline, 4-6 weeks post-nPEP initiation, and definitively at 12 weeks post-exposure to rule out HIV infection 4
Perform a laboratory-based HIV Ag/Ab test immediately before initiating nPEP to establish HIV-negative status, as recommended by the CDC 4, 5
If a rapid point-of-care test is used initially, obtain a laboratory-based Ag/Ab test simultaneously to increase diagnostic sensitivity, according to the CDC 5, 6
Perform laboratory-based Ag/Ab testing at 4-6 weeks post-nPEP initiation, as this testing can help identify potential HIV infections, although it may not rule out HIV infection due to antiretroviral suppression effects 4
A negative test at 4-6 weeks post-nPEP initiation does not rule out HIV infection because antiretrovirals from nPEP may suppress HIV detection for longer than 2 weeks after stopping medications, as noted by the CDC 4

Without NAT, there will be a diagnostic gap where highly infectious individuals may go undetected, as laboratory-based Ag/Ab tests detect HIV approximately 18-45 days post-infection, while NAT can detect infection 10-14 days earlier 4
The absence of NAT means that acute HIV infection cannot be identified as early, which is problematic because persons with acute infection are highly infectious, according to the CDC 4

The CDC strongly recommends including diagnostic NAT at both 4-6 weeks and 12 weeks for optimal sensitivity, but if NAT is unavailable, laboratory-based Ag/Ab testing alone at 12 weeks post-exposure should detect the vast majority of infections when accounting for antiretroviral washout 4, 5

The Centers for Disease Control and Prevention recommends that individuals with potential HIV exposure undergo testing at 12 weeks post-exposure with both laboratory-based antigen/antibody testing and nucleic acid testing to definitively rule out infection, as individuals with impaired immune response or HCV co-infection in the source may require extended follow-up 7, 8
Individuals with medical history suggesting inability to develop normal antibody response may require extended follow-up beyond 12 weeks, although this is not routinely recommended with modern combined Ag/Ab and NAT testing 7, 8
The CDC guidelines from 2001 recommended extended follow-up to 12 months in specific circumstances, such as HCV co-infection in the source or impaired immune response, but these recommendations predate fourth-generation testing and modern NAT 7, 8

Older guidelines (1998-2001) recommended routine testing for "at least 6 months" with consideration of extending to 12 months in rare circumstances, but these recommendations were based on third-generation antibody-only testing and did not account for modern fourth-generation Ag/Ab tests or routine NAT availability 7, 8, 9

The Centers for Disease Control and Prevention (CDC) recommends performing laboratory-based HIV antigen/antibody testing immediately before initiating post-exposure prophylaxis (PEP) to establish HIV-negative status 10
The CDC recommends performing laboratory-based Ag/Ab testing PLUS diagnostic NAT at 4-6 weeks after the exposure, and at 12 weeks post-exposure for definitive confirmation 10
A visit at 24 hours with a medical provider after starting PEP, and clinical follow-up visits at 4-6 weeks and 12 weeks after exposure for laboratory testing are recommended by the CDC 10
The CDC also recommends counseling about ongoing risk reduction and consideration of pre-exposure prophylaxis (PrEP) if the individual has continuing HIV exposure risk 10

At 4–6 weeks after exposure, both a laboratory‑based fourth‑generation HIV antibody/antigen test and an HIV RNA (nucleic acid) test should be performed; a negative result at this point does not exclude infection because antiretroviral prophylaxis can suppress viral detection. 11

A fourth‑generation HIV antibody/antigen test performed at 12 weeks (3 months) after exposure is considered definitively conclusive to rule out HIV infection after completing a 28‑day PEP course. 11
At 12 weeks, the combination of a fourth‑generation antibody/antigen test and HIV RNA testing provides a definitive assessment; ≥ 95 % of infected individuals will have detectable antibodies by this time. 11
Completion of the 12‑week definitive testing is required even if the 4–6‑week tests are negative, to account for delayed seroconversion and antiretroviral washout. 11

The International Antiviral Society‑USA panel recommends that a shorter follow‑up (e.g., 3–4 months) may be sufficient when a fourth‑generation assay is used, supporting the 12‑week conclusive timepoint after PEP. 11